Knome has added some new faces to its executive team, naming Jay Therrien as senior VP and head of global sales, Charles Abdalian as chief financial officer, and Adam Rosenberg as senior VP and head of corporate development. <\/p>\n
Therrien was VP of commercial operations and sequencing at Life Technologies, and also had spent five years in various sales leadership roles at Illumina. Abdalian recently was senior VP and CFO of Molecular Insight Pharmaceuticals, and he was senior VP of finance and CFO at Coley Pharmaceutical. Rosenberg previously was an adviser for emerging life sciences companies, co-founder of Clean Membranes, and CEO of Link Medicine. <\/p>\n
The company also has appointed Hugh Reinhoff to serve on its scientific advisory board. Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences. <\/p>\n
Pacific Biosciences said this week that Hugh Martin has resigned from its board of directors for personal reasons, effective immediately. Martin was previously the firm's president and CEO but resigned at the beginning of this year and was replaced by Michael Hunkapiller. He had led the company since 2004 and has been battling multiple myeloma, with which he was diagnosed in 2009. <\/p>\n<\/p>\n
Read more: Knome has added some new faces to its executive team, naming Jay Therrien as senior VP and head of global sales, Charles Abdalian as chief financial officer, and Adam Rosenberg as senior VP and head of corporate development. Continue reading
\nPerkinElmer's 'Ensemble for Biology' Suite Arises from 2011 Informatics Acquisitions<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"